Cerebral venous thrombosis in reproductive age

Relevance. Cerebral venous thrombosis is a relatively rare pathological condition that often leads to the development of ischemic and/or hemorrhagic stroke.

Objective. Describe a clinical case of cerebral venous thrombosis, accompanied by the ischemic stroke with hemorrhagic transformation, in a reproductive age woman taking a combined estrogen-progestin drug from the group of oral contraceptives.

Patients and methods. The analysis based on the anamnesis data, clinical, laboratory and instrumental examination of the patient.

Results. A clinical case of a 23-year-old patient who had an acute ischemic stroke with hemorrhagic transformation is presented. According to the history data and instrumental methods, the stroke was caused by thrombosis of the cerebral sinuses, which developed on the background of hormonal contraception use. The clinical case is accompanied by MRI images of the patient's brain.

Conclusions. The risk of cerebral venous thrombosis in women with hormonal contraceptives use is almost 8 times higher than in those who do not receive hormone therapy. The occurrence of neurological symptoms in women of reproductive age requires a thorough study of the life history, obstetric/gynecological and pharmacological history to establish the fact of estrogen-progestin drugs use for contraception or treatment of hormonal disorders. The described case focuses on the importance of a delicate approach to prescribing hormonal therapy in the treatment of gynecological and other pathological conditions, and indicates the necessity to consider and recommend other contraceptives for young patients.

1. Tokova Z. Z., Prilepskaya V. N., Gata A. S., Kuzemin А. А. Statistics of modern contraceptive methods in federal districts of Russia. Gynecology. 2016. Volume 18, No. 4. P. 68–71. (In Russian)

2. Curtis K. M., Tepper N. K., Jatlaoui T. C. et al. U.S. medical eligibility criteria for contraceptive use, 2016. Morbidity and mortality weekly report. Recommendations and reports. 2016. Volume 65, No. 3. P. 1–104. DOI: 10.15585/mmwr.rr6503a1.

3. Dulicek P., Ivanova E., Kostal M. et al. Analysis of risk factors of stroke and venous thromboembolism in females with oral contraceptives use. Clinical and Applied Thrombosis / Hemostasis. 2017. No. 8. DOI: 10.1177/1076029617727857.

4. Pleşa F. C., Jijie A., Toma G. S. et al. Challenges in cerebral venous thrombosis management – case reports and short literature review. Life (Basel). 2023. Volume 13, No. 2, 334. P. 1–16. DOI: 10.3390/life13020334.

5. Ferro J. M., Canhão P. Cerebral venous thrombosis: Treatment and prognosis. UpToDate. 2022. Available online: www.uptodate.com/contents/cerebral-venous-thrombosis-treatment-and-prognosis (accessed on 2 April 2023).

6. Ferro J. M., Bousser M.-G., Canhão P. et al. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – Endorsed by the European Academy of Neurology. European Journal of Neurology. 2017. No. 2. P. 195–221. DOI: 10.1111/ene.13381.

7. Moeindarbari S., Beheshtian N., Hashemi S. Cerebral vein thrombosis in a woman using oral contraceptive pills for a short period of time: A case report. Journal of Medical Case Reports. 2022. Volume 16, No. 260. P. 1–4. DOI: 10.1186/s13256–022–03473-w.

8. Pastori D., Cormaci V. M., Marucci S. et al. A comprehensive review of risk factors for venous thromboembolism: From epidemiology to pathophysiology. International Journal of Molecular Sciences. 2023. Volume 24, No. 4. P. 31–69. DOI: 10.3390/ijms24043169.

9. Xu F., Liu C., Huang X. Oral contraceptives caused venous sinus thrombosis complicated with cerebral artery infarction and secondary epileptic seizures. Medicine (Baltimore). 2017. Volume 96, No. 51. P. 1–5. DOI: 10.1097/MD.0000000000009383.

10. Ramazanov G. R., Korigova K. V., Petrikov S. S. Diagnostics and treatment of cerebral venous thrombosis. Russian Sklifosovsky Journal ‘Emergency Medical Care’. 2021. Volume 10, No. 1. С. 122–134. DOI: 10.23934/2223–9022–2021–10–1–122–134. (In Russian)